{
  "id": "5a68fd01b750ff445500001b",
  "type": "list",
  "question": "What is included in the fourth generation HIV test?",
  "ideal_answer": "Fourth generation assays detect simultaneously antibodies for HIV and the p24 antigen. It identifies HIV infection earlier than previous generation tests.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27272704",
    "http://www.ncbi.nlm.nih.gov/pubmed/28501753",
    "http://www.ncbi.nlm.nih.gov/pubmed/28872273",
    "http://www.ncbi.nlm.nih.gov/pubmed/28872274",
    "http://www.ncbi.nlm.nih.gov/pubmed/24856744",
    "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
    "http://www.ncbi.nlm.nih.gov/pubmed/28710996",
    "http://www.ncbi.nlm.nih.gov/pubmed/11595590",
    "http://www.ncbi.nlm.nih.gov/pubmed/28846743",
    "http://www.ncbi.nlm.nih.gov/pubmed/28931369",
    "http://www.ncbi.nlm.nih.gov/pubmed/28273857"
  ],
  "snippets": [
    {
      "text": "Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27272704",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Previous evaluation of the fourth-generation Alere Determine HIV-1/2 Ag/Ab Combo POCT showed only 50% sensitivity for HIV core protein p24 (p24 antigen) detection, which is suboptimal for diagnosis of acute HIV infection with limited advantage over third-generation POCT.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27272704",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: This new POCT shows improved sensitivity for detection of p24 antigen and may be of value for clinical use in detecting acute HIV infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27272704",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "While fourth generation antigen-antibody combination assays have been successful in high-resource settings, rapid point of care (POC) versions of these assays have yet to demonstrate high sensitivity to detect AHI. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28273857",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "STUDY DESIGN: A total of 30,201 sera were tested for HIV diagnosis using Abbott Architect\u00aeHIV-Ag/Ab-Combo 4th-gen-EIA at a hospital in Spain during 17 months. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28501753",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To determine if fourth-generation antigen/antibody (Ag/Ab) rapid diagnostic tests (RDT) would have detected HIV infection earlier than the third-generation RDT used in MTN-003 (VOICE).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28710996",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Fourth generation assays detect simultaneously antibodies for HIV and the p24 antigen, identifying HIV infection earlier than previous generation tests.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28846743",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The status of clients on ART was additionally confirmed by fourth-generation HIV Ag/Ab combo tests, Architect and Genscreen Ultra.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28872273",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "INTRODUCTION: We describe the overall accuracy and performance of a serial rapid HIV testing algorithm used in community-based HIV testing in the context of a population-based household survey conducted in two sub-districts of uMgungundlovu district, KwaZulu-Natal, South Africa, against reference fourth-generation HIV-1/2 antibody and p24 antigen combination immunoassays.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28872274",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The sample was later routinely tested with a fourth generation antigen/antibody assay as per local protocol and was strongly positive.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931369",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The fourth-generation HIV EIA was positive presumably because it detects p24 HIV antigen as well as antibodies, unlike rapid HIV tests and third-generation HIV EIAs.This case highlights not only the importance of frontline providers to understand the different testing methodologies for HIV screening and their limitations but the importance of clinical suspicion as well.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24856744",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This second diagnostic window was caused by the absence of HIV specific antibodies and the decline of HIV p24 antigen concentrations below the detection limits of the fourth generation assays.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11595590",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fourth- and fifth-generation HIV assays added p24 antigen detection to the screening assay, reducing the test-negative window to 11 to 14 days.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26936099",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "antibodies for HIV, p24 antigen"
}